Overview

Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fed Conditions

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
An open label randomised, two-treatment,two-period, two-sequence, single-dose, crossover, comparative bioequivalence study.
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Naproxen